{"id":141080,"date":"2022-06-25T02:22:21","date_gmt":"2022-06-25T07:22:21","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2022\/06\/human-longevity-and-freedom-acquisition-in-merger-talks"},"modified":"2022-06-25T02:22:21","modified_gmt":"2022-06-25T07:22:21","slug":"human-longevity-and-freedom-acquisition-in-merger-talks","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2022\/06\/human-longevity-and-freedom-acquisition-in-merger-talks","title":{"rendered":"Human Longevity and Freedom Acquisition in merger talks"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/human-longevity-and-freedom-acquisition-in-merger-talks2.jpg\"><\/a><\/p>\n<p>Human Longevity Inc, which was built by the pioneers of the human genome sequencing effort, and Freedom Acquisition Corporation, a publicly traded special purpose acquisition company (SPAC), have announced that they have signed a non-binding letter of intent for a proposed business combination that would result in HLI becoming a publicly listed company. Assuming everything ticks along as planned, the parties currently expect to seek approval from Freedom\u2019s shareholders by the first quarter of 2023.<\/p>\n<p><em><strong>Longevity. Technology: Unicorns are the stuff of legends and headlines, and while there can be no assurance that a definitive agreement will be entered into or that the proposed transaction will be consummated, the speculation is delicious because longevity start-ups with billion-dollar valuations mean more visible, accelerating progress for the sector. <\/strong><\/em><\/p>\n<p><strong><em>The proposed transaction values the combined company at approximately $1 billion, providing HLI with funding to pursue growth and technology innovation<\/em><\/strong><em><strong> \u2013 watch this space!<\/strong><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Human Longevity Inc, which was built by the pioneers of the human genome sequencing effort, and Freedom Acquisition Corporation, a publicly traded special purpose acquisition company (SPAC), have announced that they have signed a non-binding letter of intent for a proposed business combination that would result in HLI becoming a publicly listed company. Assuming everything [\u2026]<\/p>\n","protected":false},"author":556,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,43,269],"tags":[],"class_list":["post-141080","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-business","category-life-extension"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/141080","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=141080"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/141080\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=141080"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=141080"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=141080"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}